$3,374.97 travel Payment -- Roche/Genentech to Dr. Daniel White

Payment Details

AI-Powered Analysis of This Payment

The following analysis was generated by artificial intelligence to help patients understand the context, significance, and implications of this pharmaceutical payment. This analysis is not medical or legal advice.

Roche/Genentech made a $3.4K travel payment to Daniel White, a Pulmonology specialist in Cambridge, MA. The payment was associated with Ibrance. Roche/Genentech paid $3,374.97 for travel and lodging related to Ibrance. The payment was made to Dr. Daniel White, a Pulmonology specialist. This payment occurred on May 23, 2025, in Cambridge, MA.

Patient Guidance: What This Payment Means for You

This payment covered travel and lodging expenses for a healthcare professional, potentially related to educational events or consultations about Ibrance. Always discuss your treatment options with your healthcare provider and ask about alternatives.

Payment Context: Is This Amount Normal?

Travel and lodging payments are common in the pharmaceutical industry, especially for specialists involved with specific drugs like Ibrance, to facilitate participation in educational programs or advisory boards.

Regulatory Context: Sunshine Act Requirements

Payments for travel and lodging are reportable under the Sunshine Act, requiring disclosure to ensure transparency in the relationships between healthcare providers and pharmaceutical companies.

Related Topics

This payment is related to the following healthcare transparency topics:

• pharma-payments
• travel-and-lodging
• pulmonology
• ibrance
• roche-genentech
• open-payments

Understanding travel Payments

Travel and lodging payments cover transportation and accommodation expenses for physicians attending conferences, advisory board meetings, or speaking engagements sponsored by pharmaceutical companies. These payments can be substantial, particularly for international travel or multi-day events.

Frequently Asked Questions About This Payment

What was this $3.4K payment for?

This was a travel payment of $3.4K from Roche/Genentech to Daniel White, categorized as "Travel and Lodging". It was associated with Ibrance. The payment was reported under the Sunshine Act (CMS Open Payments).

Does Daniel White accept pharmaceutical money?

Yes, Daniel White received this $3.4K payment from Roche/Genentech. Under the Sunshine Act, pharmaceutical companies must report all payments to physicians exceeding $10. You can view Daniel White's full payment history on the CMS Open Payments database or on this site.

Is it legal for doctors to accept pharma payments?

Yes, it is legal for physicians to receive payments from pharmaceutical companies. The Physician Payments Sunshine Act (2010) requires transparency by mandating that companies report all payments exceeding $10 to CMS. These payments include consulting fees, meals, travel, speaking fees, and research grants. The law does not prohibit payments but ensures public disclosure.

Should I be concerned about this travel payment?

A travel payment of $3.4K should be evaluated in context. Payment does not imply wrongdoing, but patients have the right to ask their doctor about pharmaceutical relationships.

How do I talk to my doctor about pharma relationships?

You can ask your doctor directly: "Do you receive payments from pharmaceutical companies?" and "Does this affect which medications you prescribe?" Most doctors will answer honestly. You can also verify payment data yourself through CMS Open Payments (openpaymentsdata.cms.gov). Consider asking about generic alternatives and whether the prescribed medication is the best option regardless of manufacturer relationships.

What types of pharma payments are most concerning?

Ownership interests and large consulting/speaking fees are generally considered more significant than meals or small educational grants. Research payments typically fund clinical studies and are common in academic medicine. The total volume and concentration of payments from a single company may be more telling than any individual payment. Patterns matter more than individual transactions.

Does pharma money affect what my doctor prescribes?

Research shows that even small payments can influence prescribing behavior. Studies published in JAMA Internal Medicine found that physicians who received meals costing as little as $20 were more likely to prescribe the promoted brand-name drug. However, many physician-industry interactions are legitimate professional activities. The key is transparency and awareness.

How does this compare to other doctors in Pulmonology?

To compare this payment against Pulmonology averages, check the full specialty breakdown on CMS Open Payments. Payment amounts vary widely by specialty and type. Pulmonology physicians may receive payments for consulting, speaking, or research that are standard for the field. Individual payments should be evaluated in the context of the doctor's full payment history.

What does this payment reveal about Daniel White's relationship with Roche/Genentech?

The payment covers travel and lodging expenses. This $3.4K travel payment is part of the transparency data reported under the Sunshine Act.

Is this payment amount typical for Pulmonology?

The specific drug associated with this payment is Ibrance.

What should patients do after learning about this payment?

This payment covered travel and lodging expenses for a healthcare professional, potentially related to educational events or consultations about Ibrance.

What else should I know about this travel payment?

The payment was made to a Pulmonology specialist.

Related Reports

• View Dr. Daniel White's full payment report
• Roche/Genentech full spending report
• Browse all Pulmonology payments
• Browse all payments in Massachusetts
• Search for other payments